Cellecta, Inc.
Cellecta provides contract research services for the discovery and characterization of novel drug targets, and the development of novel therapeutics.
Cellecta’s genome-wide and targeted RNAi screening platform, which combines complex lentiviral shRNA expression libraries with HT sequencing, enables identification of genes regulating a variety of cellular responses and possible therapeutic targets and helps researchers identify new targets, prioritize known targets, characterize therapeutic mechanisms of action, and identify genes that induce an additive or synergistic response.
The approach is particularly useful in elucidating the mechanism of action for compounds and for investigators interested in identifying essential genes in cancer models.
Showing 4 of 4 products
Product A-Z
Showing 4 of 4 products

Explore our products
Show all categoriesC
Top suppliers

Carl Zeiss Microscopy
27 products

Eppendorf
1 products

Promega Corporation
11 products

Panasonic Healthcare Company
5 products

Life Technologies
1 products

Nikon Instruments Europe
11 products

Olympus Europa Holding GmbH
3 products

Leica Microsystems, Inc.
10 products

GE Healthcare Life Sciences
2 products

Tecan Trading AG
19 products

Beckman Coulter, Inc.
1 products

United States Biological
230753 products

AB SCIEX
3 products
BD (Becton, Dickinson and Company)
1 products

RANDOX TOXICOLOGY
5 products

Randox Food Diagnostics
6 products